Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.

[1]  P. Malfertheiner,et al.  Oxidative stress in ulcerative colitis-associated carcinogenesis. , 2008, Pathology, research and practice.

[2]  Ruey-Hwa Chen,et al.  The Tumor Suppressor Death-Associated Protein Kinase Targets to TCR-Stimulated NF-κB Activation1 , 2008, The Journal of Immunology.

[3]  S. Itzkowitz,et al.  Cancer in inflammatory bowel disease. , 2008, World journal of gastroenterology.

[4]  A. Kimchi,et al.  DAP kinase regulates JNK signaling by binding and activating protein kinase D under oxidative stress , 2007, Cell Death and Differentiation.

[5]  J. Issa,et al.  Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. , 2007, Gastroenterology.

[6]  P. Malfertheiner,et al.  Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression. , 2007, Neoplasia.

[7]  J. Jass,et al.  Low frequency of promoter methylation of O6-methylguanine DNA methyltransferase and hMLH1 in ulcerative colitis-associated tumors: comparison with sporadic colonic tumors. , 2007, American journal of clinical pathology.

[8]  M. Vieth,et al.  DAPK promotor methylation is an early event in colorectal carcinogenesis. , 2006, Cancer letters.

[9]  P. Laird,et al.  CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.

[10]  P. Rabinovitch,et al.  Cancer surveillance in inflammatory bowel disease: new molecular approaches , 2006, Current opinion in gastroenterology.

[11]  A. Zinsmeister,et al.  Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. , 2006, Gastroenterology.

[12]  R. Schneider-Stock,et al.  Close localization of DAP‐kinase positive tumour‐associated macrophages and apoptotic colorectal cancer cells , 2006, The Journal of pathology.

[13]  A. Forbes,et al.  Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. , 2006, Gastroenterology.

[14]  T. Ohkusa,et al.  Disruption of the p53–p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis , 2006, International journal of cancer.

[15]  G. Watanabe,et al.  DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer , 2006, British Journal of Cancer.

[16]  J. Joseph,et al.  Death-associated Protein Kinase as a Sensor of Mitochondrial Membrane Potential , 2005, Journal of Biological Chemistry.

[17]  P. Marjoram,et al.  The Molecular Signature of Normal Squamous Esophageal Epithelium Identifies the Presence of a Field Effect and Can Discriminate between Patients with Barrett's Esophagus and Patients with Barrett's-Associated Adenocarcinoma , 2005, Cancer Epidemiology Biomarkers & Prevention.

[18]  C. Yu,et al.  Aberrant CpG island methylation in early-onset sporadic gastric carcinoma , 2005, Journal of Cancer Research and Clinical Oncology.

[19]  Noam Harpaz,et al.  Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability. , 2005, Gastroenterology.

[20]  T. Fujimori,et al.  Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis , 2005, Gut.

[21]  S. Itzkowitz,et al.  Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[22]  Alastair Forbes,et al.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.

[23]  Hyeon Joo Lee,et al.  Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. , 2003, The American journal of pathology.

[24]  K. Chayama,et al.  The promoter methylation status of the DNA repair gene O6-methylguanine-DNA methyltransferase in ulcerative colitis , 2003, Virchows Archiv.

[25]  Tsung-Teh Wu,et al.  Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  S. Lam,et al.  Epigenetic down-regulation of death-associated protein kinase in lung cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  H. Kuwano,et al.  High frequency of DAP-kinase gene promoter methylation in colorectal cancer specimens and its identification in serum. , 2003, Cancer letters.

[28]  Jie Liao,et al.  Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. , 2003, Carcinogenesis.

[29]  S. Toyooka,et al.  Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. , 2002, Cancer research.

[30]  Nita Ahuja,et al.  DNA methylation and environmental exposures in human hepatocellular carcinoma. , 2002, Journal of the National Cancer Institute.

[31]  F. Waldman,et al.  The APC/β‐catenin pathway in ulcerative colitis–related colorectal carcinomas , 2002, Cancer.

[32]  Suna Wang,et al.  Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. , 2002, Cancer research.

[33]  N. Ahuja,et al.  Accelerated age-related CpG island methylation in ulcerative colitis. , 2001, Cancer research.

[34]  P. Dickman,et al.  Family history as a risk factor for colorectal cancer in inflammatory bowel disease. , 2001, Gastroenterology.

[35]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[36]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[37]  W. H. Kim,et al.  CpG island methylation in premalignant stages of gastric carcinoma. , 2001, Cancer research.

[38]  W. Bodmer,et al.  Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer , 2001, Gut.

[39]  P. Dickman,et al.  Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study , 2001, The Lancet.

[40]  P. Laird,et al.  Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. , 2000, Cancer research.

[41]  K Raja,et al.  Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. , 2000, Cancer research.

[42]  C. Fenoglio-Preiser,et al.  Microsatellite instability and K-ras mutations in patients with ulcerative colitis. , 2000, Human pathology.

[43]  S. Baylin,et al.  Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. , 1999, Cancer research.

[44]  A. Kimchi,et al.  Dap-Kinase Participates in TNF-α–And FAS-Induced Apoptosis and Its Function Requires the Death Domain , 1999, The Journal of cell biology.

[45]  H. Mitomi,et al.  Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF1/CIP1 expression in ulcerative colitis. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[46]  C. Hsieh,et al.  Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. , 1998, Cancer research.

[47]  S. Polak‐Charcon,et al.  DAP kinase links the control of apoptosis to metastasis , 1997, Nature.

[48]  A. Kimchi,et al.  DAP‐kinase is a Ca2+/calmodulin‐dependent, cytoskeletal‐associated protein kinase, with cell death‐inducing functions that depend on its catalytic activity , 1997, The EMBO journal.

[49]  Sajeev P. Cherian,et al.  Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. , 1996, Cancer research.

[50]  J. Benhattar,et al.  Molecular genetics of dysplasia in ulcerative colitis. , 1995, European journal of cancer.

[51]  N. Harpaz,et al.  Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. , 1995, Cancer research.

[52]  N. Harpaz,et al.  p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. , 1993, Gastroenterology.

[53]  H. Adami,et al.  Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.

[54]  J. Lennard-jones,et al.  Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. , 1990, Gut.

[55]  Makoto Watanabe,et al.  Aberrant DNA methylation in ulcerative colitis without neoplasia. , 2008, Hepato-gastroenterology.

[56]  Jia-Yun Chen,et al.  TGF-β induces apoptosis through Smad-mediated expression of DAP-kinase , 2002, Nature Cell Biology.

[57]  Gustavo Droguett,et al.  DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation , 2000, Nature Cell Biology.

[58]  A. Kimchi,et al.  Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. , 1995, Genes & development.